GLP-1 support: Bank of America spends more than $250 million annually covering GLP-1 weight loss drugs for employees, with CEO Brian Moynihan calling the expense a worthwhile investment because of its…
GLP-1 support: Bank of America spends more than $250 million annually covering GLP-1 weight loss drugs for employees, with CEO Brian Moynihan calling the expense a worthwhile investment because of its…